article thumbnail

Torrent Pharma to acquire Curatio for $245.16m

Pharmaceutical Technology

Holding a presence in the cosmetic dermatology sector, Curatio’s portfolio comprises more than over 50 brands that are commercialised in India. The portfolio includes brands such as Tedibar, Atogla, Spoo, B4 Nappi and Permite. Among these facilities, four are approved by the US Food and Drug Administration (FDA).

article thumbnail

Novo’s obesity drug has serious warnings and barriers to overcome

World of DTC Marketing

SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?

Drugs 318
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is a natural health product? Health Canada’s findings upheld by Federal Courts

Pharma in Brief

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. In its August 16, 2023 decision in Le-Vel Brands, LLC v. Natural health product vs. regulated drug In Winning Combination Inc.

article thumbnail

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

FDA Law Blog

The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. Claud will be featured at the Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products in New York, NY.

article thumbnail

Eli Lilly’s Weight-Loss Drug, Mounjaro, Sparks an Epic Run in Pharma Shares

Roots Analysis

Renowned for psychiatric drugs such as Prozac, the company faced several challenges in revenue generation during the 2010s due to patent expiration of its innovative drugs. However, a strategic shift and a focus on innovative treatments have catapulted Eli Lilly to unprecedented heights, especially in the field of anti-obesity drugs.

Drugs 40
article thumbnail

State Drug Importation Bills Just Got More Personal in California

Pharmacy Checkers

With lies and deception, Big Pharma has used the threat posed by rogue websites and counterfeit drugs to push back against U.S. state legislation to gain access to lower drug prices in Canada. Simple summary: Canada’s brand drugs are priced much lower and states want access to them. There’s no gray in that statement.

Drugs 71
article thumbnail

Scientists Urge the FDA to Ban Red 3 Color Additive

XTalks

In the US, it’s against the law to use the carcinogenic color additive Red 3 in cosmetics, such as lipsticks or blush or topicals. As a result, in 1990, the agency eliminated certain “provisionally listed” uses of the chemical — meaning cosmetics and externally applied drugs. But those steps were never taken.